These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15229530)

  • 1. DNA vaccines--back in the saddle again?
    Powell K
    Nat Biotechnol; 2004 Jul; 22(7):799-801. PubMed ID: 15229530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APHIS: West Nile virus vaccine safe for use.
    Kahler SC
    J Am Vet Med Assoc; 2003 Aug; 223(4):416-8. PubMed ID: 12930068
    [No Abstract]   [Full Text] [Related]  

  • 3. West Nile virus vaccines.
    Hall RA; Khromykh AA
    Expert Opin Biol Ther; 2004 Aug; 4(8):1295-305. PubMed ID: 15268663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study: West Nile virus cost equine industries in Colorado, Nebraska millions in 2002.
    J Am Vet Med Assoc; 2003 Jun; 222(12):1669, 1672. PubMed ID: 12830851
    [No Abstract]   [Full Text] [Related]  

  • 5. Equine vaccine for West Nile virus.
    Ng T; Hathaway D; Jennings N; Champ D; Chiang YW; Chu HJ
    Dev Biol (Basel); 2003; 114():221-7. PubMed ID: 14677692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. West Nile virus in horses - What do you need to know to diagnose the disease?
    Paré J; Moore A
    Can Vet J; 2018 Oct; 59(10):1119-1120. PubMed ID: 30510321
    [No Abstract]   [Full Text] [Related]  

  • 7. The anamnestic serologic response to vaccination with a canarypox virus-vectored recombinant West Nile virus (WNV) vaccine in horses previously vaccinated with an inactivated WNV vaccine.
    Grosenbaugh DA; Backus CS; Karaca K; Minke JM; Nordgren RM
    Vet Ther; 2004; 5(4):251-7. PubMed ID: 15719324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
    El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance for antibodies to West Nile virus in Ireland.
    Raleigh PJ; Sammin DJ; Connell J; Markey BK; O'Connor M
    Vet Rec; 2012 Feb; 170(7):180. PubMed ID: 22238203
    [No Abstract]   [Full Text] [Related]  

  • 10. Views WNV prevention suggestions as outdated.
    Reilly FK
    J Am Vet Med Assoc; 2004 Oct; 225(7):1027-8. PubMed ID: 15515977
    [No Abstract]   [Full Text] [Related]  

  • 11. West Nile virus in the United States (1999-2005).
    Gerhardt R
    J Am Anim Hosp Assoc; 2006; 42(3):170-7. PubMed ID: 16611928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Cross-Protection of a Lineage 1 West Nile Virus Inactivated Vaccine against Natural Infections from a Virulent Lineage 2 Strain in Horses, under Field Conditions.
    Chaintoutis SC; Diakakis N; Papanastassopoulou M; Banos G; Dovas CI
    Clin Vaccine Immunol; 2015 Sep; 22(9):1040-9. PubMed ID: 26178384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge.
    Minke JM; Siger L; Karaca K; Austgen L; Gordy P; Bowen R; Renshaw RW; Loosmore S; Audonnet JC; Nordgren B
    Arch Virol Suppl; 2004; (18):221-30. PubMed ID: 15119777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses.
    Siger L; Bowen RA; Karaca K; Murray MJ; Gordy PW; Loosmore SM; Audonnet JC; Nordgren RM; Minke JM
    Am J Vet Res; 2004 Nov; 65(11):1459-62. PubMed ID: 15566080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experiences with new generation vaccines against equine viral arteritis, West Nile disease and African horse sickness.
    MacLachlan NJ; Balasuriya UB; Davis NL; Collier M; Johnston RE; Ferraro GL; Guthrie AJ
    Vaccine; 2007 Jul; 25(30):5577-82. PubMed ID: 17267078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).
    Rosas CT; Tischer BK; Perkins GA; Wagner B; Goodman LB; Osterrieder N
    Virus Res; 2007 Apr; 125(1):69-78. PubMed ID: 17241683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacies of three commercially available vaccines against West Nile Virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model.
    Seino KK; Long MT; Gibbs EP; Bowen RA; Beachboard SE; Humphrey PP; Dixon MA; Bourgeois MA
    Clin Vaccine Immunol; 2007 Nov; 14(11):1465-71. PubMed ID: 17687109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection provided by a recombinant ALVAC(®)-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain.
    Minke JM; Siger L; Cupillard L; Powers B; Bakonyi T; Boyum S; Nowotny N; Bowen R
    Vaccine; 2011 Jun; 29(28):4608-12. PubMed ID: 21549780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. West Nile virus infection of horses.
    Castillo-Olivares J; Wood J
    Vet Res; 2004; 35(4):467-83. PubMed ID: 15236677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. West Nile virus revisited and other mosquito borne viruses of horses in Australia.
    Studdert MJ
    Aust Vet J; 2003; 81(1-2):56-7. PubMed ID: 15084012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.